4/29/2029

Shareholder Activism in Asia Drives Global Total to Record High

Nikkei Asia (04/29/29) Shikata, Masayuki

Activist shareholders had their busiest year on record in 2024, with the Asia-Pacific region making up a fifth of campaigns worldwide, pushing some companies higher in the stock market and spurring others to consider going private. The worldwide tally of activist campaigns rose by six to 258, up by half from three years earlier, according to data from financial advisory Lazard. Campaigns in the Asia-Pacific tripled over that period to 57, growing about 30% on the year. Japan accounted for more than 60% of the regional total with 37, an all-time high. Activity is picking up this year as well in the run-up to general shareholders meetings in June. South Korea saw 14 campaigns, a jump of 10 from 2023. Critics say South Korean conglomerates are often controlled by minority investors that care too little about other shareholders. Australia and Hong Kong saw increases of one activist campaign each. North America made up half the global total, down from 60% in 2022 and 85% in 2014. Europe had 62 campaigns last year. The upswing in Japan has been fueled by the push for corporate governance reform since 2013 and the Tokyo Stock Exchange's 2023 call for companies to be more mindful of their share prices. The bourse has encouraged corporations to focus less on share buybacks and dividends than on steps for long-term growth, such as capital spending and the sale of unprofitable businesses. Demands for capital allocation to improve return on investment accounted for 51% of activist activity in Japan last year, significantly higher than the five-year average of 32%. U.S.-based Dalton Investments called on Japanese snack maker Ezaki Glico (2206) to amend its articles of incorporation to allow shareholder returns to be decided by investors as well, not just the board of directors. Though the proposal was rejected, it won more than 40% support, and Glico itself put forward a similar measure that was approved at the following general shareholders meeting in March. U.K.-based Palliser Capital took a stake last year in developer Tokyo Tatemono (8804) and argued that more efficient use of its capital, such as selling a cross-held stake in peer Hulic, would boost corporate value. Activist investors are increasingly seeking to lock in unrealized gains from rising land prices, reaping quick profits from property sales that can go toward dividends. Companies in the Tokyo Stock Exchange's broad Topix index had 25.88 trillion yen ($181 billion at current rates) in unrealized gains on property holdings at the end of March 2024, up about 20% from four years earlier. After buying into Mitsui Fudosan (8801) in 2024, U.S.-based Elliott Investment Management this year took a stake in Sumitomo Realty & Development (8830) and is expected to push for the developer to sell real estate holdings. This month, Dalton sent a letter to Fuji Media Holdings (4676), parent of Fuji Television, calling for it to spin off its real estate business and replace its board of directors. Activist campaigns have sparked share price rallies at some companies. Shares of elevator maker Fujitec (6406) were up roughly 80% from March 2023, when it dismissed Takakazu Uchiyama -- a member of the founding family -- as chairman under pressure from Oasis Management. The rise in demands from activists "creates a sense of tension among management, including at companies that don't receive such proposals," said Masatoshi Kikuchi, chief equity strategist at Mizuho Securities. Previously tight cross-shareholdings are being unwound, and reasonable proposals from minority investors are more likely to garner support from foreign shareholders. Some companies are going private to shield themselves from perceived pressure. Investments by buyout funds targeting mature companies in the Asia-Pacific were the highest in three years in 2024, according to Deloitte Touche Tohmatsu. Toyota Industries (6201) is considering going this route after facing pressure from investment funds last year to take steps such as dissolving a parent-child listing with a subsidiary and buying back more shares. Toyota Industries holds a 9% stake in Toyota Motor (7203). The automaker "may have proposed having [Toyota Industries] go private as a precautionary measure," said a source at an investment bank.

Read the article

11/5/2025

Carl Icahn, Nearing 90, Is Still Trying to Right His Empire

Wall Street Journal (11/05/25) Lombardo, Cara

Activist investor Carl Icahn says nothing compares to the thrill of being immersed in a fight. For the past few years, the 89-year-old billionaire has been playing defense on several fronts. He is trying to revive the fortunes of Icahn Enterprises (IEP), the publicly traded company that houses his investments, after a 2023 short-seller attack shaved billions off its market value and his own net worth. But a relationship with one member of the investing team recently turned contentious. And he feels it has become next to impossible for activists to wage the types of shareholder fights he loves and that have made him a fortune. On the home front, as he nears his 90th birthday, he’s faced recent health scares. Icahn remains his combative self, publicly denying he’s concerned about any of it and focused on what he sees as momentum. “I keep going,” he said in one of several interviews over the past month. “I enjoy the game.” He describes the third-quarter earnings his firm reported Wednesday as some of its “best ever,” and he plans to unveil two new investments soon. He is obsessed with a pet project focused on removing voting power from index funds, which he believes could restore activists’ bite. Shares in Icahn Enterprises, known by its ticker IEP, are down roughly 80% from before the short seller arrived. Hindenburg Research, now defunct, had alleged IEP was overvalued and vulnerable from its founder borrowing against its shares. Forbes estimates that Icahn’s net worth is now closer to $4.5 billion, down from above $17 billion years a few years ago. “They took part of my army away, like Alexander the Great,” Icahn said of the attack, which dented his capacity to make new investments. “He has to change his battle plans, but it’s not that bad.” Icahn likes to point out that the IEP stock continued paying annualized dividends of $2 a share throughout the ordeal. IEP reported net income of $287 million in its third quarter, up from $22 million a year ago. The value of IEP’s investments, its net asset value, rose to $3.8 billion, up $567 million since June 30, primarily due to CVR Energy (CVI), a small refiner it controls. The increase would have been even higher, if not for short positions Icahn has long maintained as a hedge. Soon, IEP will reveal a big stake in automotive service chain Monro (MNRO), people familiar with the matter said. IEP, which holds board seats on seven public companies excluding those it controls, is also in talks to join the board of another company, the people said. Inside IEP, succession remains murky, some recent hires have soured and blockbuster wins have been missing. Brett Icahn, Carl’s son, officially rejoined the firm in October 2020, signing a seven-year contract to lead a team of three investors he hired. Brett is expected to succeed his father as chairman and run the firm’s investment unit. Icahn says he is devoting much of his energy to targeting index funds’ voting rights. He is finishing a white paper on the topic. He rails against what he calls the “cartel” of BlackRock, Vanguard, and State Street. The way Icahn sees it, with index funds controlling around 30% of most companies’ voting rights, it has become impossible for activist investors to run proxy fights for control of corporate boards. He argues such fights are good for the overall economy, but rarely win support from the index funds. BlackRock and its peers say they are giving some investors voting powers and otherwise carefully determine votes delegated to them to maximize investors’ financial interests. They also point to legal issues that currently prevent them from giving all investors the ability to vote their own shares. Icahn wants either Congress to act or President Trump to issue an executive order. One proposal from Republican lawmakers would require shares held in passively managed funds to be voted on a proportional basis according to instructions from fund investors.

Read the article

11/5/2025

The Secret Weapon Boards are Deploying to Survive AGM Season

Australian Financial Review (11/05/25) Durkin, Patrick

Brunswick Group is one of the growing swell of board advisers and proxy solicitation firms fighting back against the influential proxy advice firms and in-house governance teams at superannuation funds that recommend how Australia’s biggest investors should cast their votes at annual shareholder meetings. Others include Georgeson (owned by share registry Computershare), Sodali (formerly Morrow Sodali), and local player OpenEngagement. Working behind the scenes, little is known about them — but they have a growing battle on their hands.  As the historic votes at last week’s annual meetings at building materials group James Hardie (JHIUF), where the chairman was ousted, and CSL Ltd (CSL), where 42% of shareholders voted against the biotechnology company’s executive pay proposal, showed, proxy advisers and Australia’s largest investors are angry and not afraid to show it. Protest votes against executive pay have hit record highs. In 2023 and 2024 there were 41 and 40 strikes respectively against remuneration plans at ASX 300 companies, up from 26 or fewer in each of the previous four years. Individual directors are being engaged more than ever before. James Hardie lost three directors while Super Retail chairwoman Judith Swales faced a 25% protest vote. Several proxy firms which include CGI, Institutional Shareholder Services (ISS), and local players Ownership Matters and Australian Council of Superannuation Investors (ACSI), have tightened their guidelines for voting across director tenure, potential audit conflicts and CEO share sales. As an advocate of company boards, the proxy solicitation firms analyze the company shareholder registries, working out who actually casts the vote on the AGM resolutions and tries to convince them of the company’s position. They also try to ensure investors who are supportive of any given resolution get out and vote. The majority of ASX listed companies hold their AGM in the six weeks between late October and early December. A notice of meeting is sent 30 days before the AGM. The proxy firms’ voting recommendations typically arrive two weeks out, with proxy votes due 48 hours before the meeting. That’s the narrow window when these behind-the-scenes operatives go to work, trying to convince investors to side with the board. Some in the industry claim the proxy firms can sway between 10 and up to 30% of the vote. The dominance of Australia’s super sector, which now owns almost a quarter of all ASX-listed securities, is another big challenge for boards. While some funds outsource their investment decisions, they often retain in-house governance teams who retain control of the AGM vote. ISS is cracking down on directors with a potential audit conflict such as new ASX director and ex-PWC partner Anne Loveridge. She was hit with a 16.8% protest vote at the exchange's AGM in October after ISS flagged concerns over the exchange's use of PwC as its auditor and her role as chair of the audit committee. ISS claims that any director who previously worked at the company's auditor, particularly if they sit on the company audit committee, faces a potential conflict. ISS also says it will vote against directors and chairs who have served more than 16 years on the board. Beyond the big super funds, there is also the growing group of activist investors. The Australasian Centre for Corporate Responsibility and Market Forces has made a name bringing resolutions against top listed companies in recent years and now new player the Sustainability Investment Exchange (SIX), a share trading platform that combines activism and investing, is broadening the agenda.

Read the article

11/4/2025

The Gamble Behind a Big Takeover of Tylenol’s Maker

New York Times (11/04/25) Hirsch, Lauren

Kimberly-Clark’s (KMB) $40 billion deal for Kenvue (KVUE), the embattled maker of Tylenol and other consumer products, seemingly flies in the face of two M.&A. maxims: skirt uncertainty whenever possible, and avoid inviting scrutiny by the Trump administration. Talks began after Kenvue announced a strategic review in July, effectively putting itself up for sale. The company was already under pressure from shareholders, including the activist investor Starboard Value, whose co-founder, Jeff Smith, joined its board in March. In September, the Trump administration linked the use of Tylenol during pregnancy to autism, a connection that the company has strongly denied. That turmoil hovered over deal talks and helped Kimberly-Clark push for an agreement that valued Kenvue at a discount to its peers. (The transaction values Kenvue at $21.01 a share, only slightly above where the company was trading before word of the administration’s plans emerged.) One big question: Did the companies give federal officials a heads-up about the deal? That tactic, which has grown popular during the second Trump administration, may have bolstered executives’ confidence. The Kenvue deal is a bet that the markets have overreacted. Kimberly-Clark has long been interested in acquiring Kenvue, given its well-known brands and overlap in customers, said people with knowledge of the deal. Company executives told analysts on Monday that they worked with legal, health and government experts to do thorough due diligence. They seemingly concluded that the cost and uncertainty of buying Kenvue were outweighed by the quality of the target company’s brands — and the price they would pay. (Among the winners of the deal were the many activist investors in Kenvue’s stock.) Many shareholders in Kimberly-Clark seem to think that the company didn’t get enough of a discount: Its shares fell down nearly 15% on Monday. Kimberly-Clark probably can’t cite litigation risk as an escape hatch. Regulatory filings by the company published on Monday showed that business pressures related to acetaminophen or talc, whose legal liability Kenvue has assumed from Johnson & Johnson outside the United States and Canada, don’t appear to qualify as acceptable reasons to walk away. However, there is a caveat to that carve-out in a disclosure letter by Kenvue that hasn’t been publicly filed yet. There could be other ways to kill the deal. Both Kenvue and Kimberly-Clark stockholders must vote on the transaction. But with a final deadline for closing set for the second half of 2026, shareholders most likely won’t vote for months, according to Eric Talley, a professor at Columbia Law School. “If Kenvue gets clobbered by Tylenol liability in the meantime, Kimberly-Clark stockholders are unlikely to approve the deal,” Talley told DealBook. “If Kenvue runs the table and escapes all liability risk, its own stockholders may bridle and vote the deal down.”

Read the article

11/4/2025

Commentary: What Could Stop Kimberly-Clark’s Deal for Kenvue

Barron's (11/04/25) Bary, Andrew

The fall in Kimberly-Clark’s (KMB) stock continued for a second day and raised the prospect that an activist investor could surface and try to block its merger-of-equals deal with Tylenol maker Kenvue (KVUE). Kimberly-Clark’s stock is down 1.7% to $100.55 after hitting a new 52-week low earlier in the session on Tuesday. The stock fell 15% on Monday and is way below its 52-week high of $150. The shares are in the red over the past one, five, and 10 years as well. The Kimberly-Clark/Kenvue transaction is one of the worst-received major merger deals in recent years. Investors wondered why Kimberly-Clark was willing to buy a company with weakening sales and sizable potential legal liability related to Tylenol and talc. The deal requires shareholder approval from both Kimberly-Clark and Kenvue. An okay is likely from Kenvue holders since Kimberly-Clark is throwing the company a lifeline, but it is less certain with Kimberly-Clark. An activist could accumulate a stake in Kimberly-Clark and push its shareholders to reject the deal, which is due to close in the second half of next year. The activist’s bet would be that Kimberly-Clark stock would rally if the deal is voted down by shareholders. If a powerful activist firm surfaces in Kimberly-Clark, the stock likely would rally. One hurdle for an activist is that the deal requires a majority of shares voted, not total shares outstanding, to clear. That provision makes it easier for the company to get approval since a certain percentage of holders won’t cast votes. Kimberly-Clark is offering a package of stock and cash (mostly stock) that is now worth around $18.15 a share (nearly 0.15 shares of stock and $3.50 in cash per Kenvue share), Barron’s estimates. Kenvue stock is up 0.4% at $16.21 and trades at about an 11% discount to the current deal value. That’s a wider arbitrage spread than would likely prevail in a deal with a scheduled closing in about a year. But the second-half 2026 closing could be optimistic given necessary regulatory approvals, including apparently from China. The longer the time until closing, the wider an arbitrage spread should be. And there is a chance that Kimberly-Clark holders will reject the deal. Kimberly-Clark hailed the deal to bring together “two iconic companies” and said the transaction is “attractive” financially and offers “compelling value creation for all shareholders.” One problem is that earning accretion may not occur until 2028, according to Citi analyst Filippo Falorni. In a client note, he saw the potential for over $8 a share in 2028 earnings for the combined companies. The deal also would leave the two companies with over $20 billion in debt, or nearly three times projected Ebitda, or earnings before interest, taxes, depreciation, and amortization.

Read the article

10/31/2025

A Decade of Digital Dominance

Houston Business Journal (10/31/25) Nair, Jishnu

Hewlett Packard Enterprise (HPE) CEO Antonio Neri discusses benefits of its $14 billion Juniper acquisition and addresses the scrutiny of the deal. Last year, HPE brought in $30.1 billion, the most the company has made since the onset of the Covid-19 pandemic. Neri attributed much of that growth to the company’s investments in AI since 2023, which involved a restructuring of HPE's business segments and several new leaders. Earlier this year, HPE also completed what Neri referred to as the biggest deal of his tenure as CEO: the $14 billion acquisition of Juniper Networks. Together with HPE’s Aruba line, the addition of Juniper is intended to create the connective tissue for the AI investments that other giant companies are making, like data centers and large-language models. “The last two years has been an explosion of generative AI,” Neri said. “But now with agentic AI on the way, and then reasoning and robotics, HPE is in a good position to power the computational needs to be able to deliver on that opportunity. "We play in every segment of the market, enterprise, sovereign and service providers. And we enable the builders to train their models. HPE is vastly different from 10 years ago, and this is going to be good for shareholders because (as) we grow profitably with higher margin structure, we’ll be able to return much more capital to shareholders through dividends.” It hasn’t all been smooth sailing, though. HPE has seen interest from prolific activist investor Elliott Investment Management, and the Department of Justice challenged the Juniper deal in courts this year before ultimately settling with HPE — though questions are being raised about the settlement. If the Juniper deal hadn’t gone through for whatever reason, HPE had alternatives, Neri said. But the completed acquisition now gives HPE an opportunity to build a household name in networking. “For us to make a difference in our business, you have to build a billion-dollar franchise,” he said. “Otherwise, it’s too small to be seen … and that’s why this was the right transaction at the right time.” For the business, HPE is projecting that Juniper will help generate over $3.5 billion in free cash flow by 2028. The company has already announced a 10% dividend increase in the first quarter of 2026. But on the technical side, Juniper’s network offerings will help bring wider infrastructure to the growing number of data centers springing up across the nation, Neri said. The DOJ raised questions about the scale of the combined company, arguing in court that it would allow HPE to dominate the networking market, though ultimately the federal government settled for forcing HPE to sell its Instant On business aimed at networking for small businesses. For his part, Neri remained adamant that this deal would bring HPE in line with competitors rather than overwhelm them. “The environment is different than maybe five years ago, but my view of this is very simple,” he said. “This is pro-competitive, and this is absolutely important for national security, because one of the things nobody speaks about is that HPE — between networking and compute and storage — is now the only company that has the full stack. "With our experience in (telecommunications), we can actually go and replace Huawei around the globe.”

Read the article

10/31/2025

Commentary: Cevian Can Dust Off Its Aviva Playbook for Axa

Reuters Breakingviews (10/31/25) Donnellan, Aimee

Cevian is experienced in nudging insurance companies in the direction of its choosing. In 2021 the Swedish activist bought a 5% stake in $27 billion Aviva (AVVIY). Its playbook is simple: find an undervalued group in the midst of a turnaround, and push for M&A or a release of capital. Given its lackluster valuation, 83 billion euro French insurer Axa (AXAF) would be a suitable target. Four years ago, Aviva was valued at just 8 times its expected earnings compared to rivals valued at 13 times. Shareholders weren’t convinced CEO Amanda Blanc could close the gap. When Cevian swooped in, the activist called on her to release 5 billion pounds of excess capital and cut 500 million pounds worth of costs — both asks that were slightly beefed up versions of her existing plan. Either way, when Cevian sold most of its shares in 2023 Blanc had overdelivered on its requests: Aviva’s share price had increased by nearly 25%. Axa’s Thomas Buberl could do with similar backing. Last year, the insurance boss unveiled his “unlock the future” plan, which involves ramping up earnings per share, increasing return on equity to between 14% and 16% and sharing 17 billion euros of capital with shareholders. He also plans to return 75% of newly generated capital via dividends and buybacks. Luckily for him, the group's three main divisions — property and casualty, health and asset management — are growing gangbusters. Over the next five years, Axa's revenue is expected to rise by an average annual rate of 10%, according to LSEG forecasts. Investors, however, are giving Buberl very little credit. Axa currently trades on just 9.5 times its expected earnings, compared to 11 and nearly 12 times respectively for fellow global insurers Aviva and Allianz (ALVG). As recently as last year, they all traded on roughly the same multiple. Some of this can be blamed on Axa’s home market. France is in the midst of political and economic turmoil, and Axa generates around 10% of its taxable earnings in Europe’s second largest economy. If President Emmanuel Macron decides to hike corporate taxes, this figure will decline. Still, Axa if anything has excess capital. Its solvency ratio, calculated by dividing the company's actual capital by the minimum amount of capital required by the regulator, was up 2 percentage points at 222% at its nine-month results on Thursday. That implies Axa has more than double the capital required to cover its financial risks. Cevian could push for the insurer to return some of that pile. It could also encourage Buberl to sell the group's reinsurance arm, which could fetch close to 4 billion euros, according to a source who reckons its 500 million euros of earnings would be valued on 7 times. The activist has a reputation for being more of a supportive shareholder than an uppity one. Axa’s discount valuation suggests it could use a new cheerleader.

Read the article

10/31/2025

Commentary: What Peltz’s Janus Swoop Really Means

Citywire (10/31/25) Sloley, Chris

Will Trian’s push to take the British-American money manager private have wider ramifications for listed players? This is not the first time Nelson Peltz has parked his metaphorical activist tanks on Janus Henderson’s (JHG) lawn. In 2022, the doyenne of Trian Fund Management upped his stake in the US-based asset manager and called for upheaval. Installing himself on the board alongside Trian’s CIO Ed Garden in February of that year, the high-profile investor pushed for change, and, it would seem, Ali Dibadj was more than willing to turn things around at the fund house. Dibadj stepped in as CEO in June 2022 and outlined extensive plans for cost-cutting, to the tune of $45m (CHF 36.1m) in early ideas, and secured inflows through deals and strategic changes which stemmed a sustained period of outflows. Apparently sated, Peltz ceded his board seat to a colleague and talk of more aggressive action subsided.  So, why has Peltz decided now is the time to take the stable company private – and could this mean a push among other asset management players considering the same? Trian's 13F filing for June - which showcases all its major positions - has Janus Henderson at 32% of the portfolio, with Peltz and his colleagues owning 20.4% of outstanding Janus Henderson shares at present. The non-binding proposal that surfaced earlier this week, which has been issued in partnership with General Catalyst, values Janus at a premium of $46 per share over its market close of $41 on Friday of last week.  This brings the overall valuation of the company to $7.1bn, which means Trian sees unrealized value still being left on the table. When Peltz and Trian previously boosted their bets in Janus Henderson in 2022 there was a sense among market commentators that the long-term aim for the company was consolidation. They were credited as having help chivvy Legg Mason along into its eventual takeover by Franklin Templeton using their minority stake as a driving force and talk had grown over Peltz using stakes in Invesco and Janus Henderson to pull many companies together into one considerably larger player. BNP Paribas Asset Management's absorption of Axa Investment Managers earlier this summer — a move to make a new power in Europe with €880bn in assets — showed the opportunity for improving scale is possible and perhaps has Trian on high alert for US or Europe-based equivalents. Janus Henderson Global Investors is already a merged entity, having been a marriage of equals among the former Janus Capital and Henderson Global Investors, but being a fund house with $457bn in assets puts the combined company into the industry's "floating middle" — firms too small to be one-stop shops and too big to be specialist boutiques. Dibadj has gone some way to address gaps in the company's specialisms with deals for ETF specialist Tabula Investment Management, a stake in private credit manager Victory Park and private equity group NBK Capital Partners, all in 2024. But is this enough to ensure continued growth without the need for Trian and General Catalyst? Janus Henderson has remained tight-lipped in its response to the deal beyond stating a special committee has been convened to consider the proposal thoroughly, with Dibajd deflecting questions on an earnings call beyond saying it will take months and not weeks to consider the proposal. Analysts in the US have already indicated that Trian's push could lead to other asset managers considering moving to private management, as it would lessen the need to meet quarterly demands and questions from shareholders while being able to innovate and grow. This was one of the key reasons cited by Peltz and General Catalyst's Hemant Taneja. Peltz is a meticulous operator who tends to get what he wants and acts with authority — his Lunch with the FT profile begins with him getting the restaurant to turn down the music (he owns the building which houses the restaurant in question, FYI). In the same profile, he pointed to not using "funny money crap" and leverage in his deals and views himself as someone buying good companies "missing a little bit." The topic of that discussion was Disney, which is now the home of The Simpsons. In The Simpsons, many characters are harangued by a boy who is quick to point out their ineptitude with a pointed "ha ha!" While Nelson Muntz is a comedy invention, Nelson Peltz may be no laughing matter for listed asset managers.

Read the article

10/30/2025

Analysis: Hostile M&A Activity Could Spur Comeback of Takeover Defenses

Bloomberg Law (10/30/25) Aquila, Frank; Yuh, Catherine

Unsolicited mergers and acquisitions bids in 2025 have made for eye-popping headlines, and robust unsolicited M&A activity is likely to continue, even in volatile markets. A public acquisition bid places immense pressure on the target company’s board and management. Unsolicited bids typically appear with little notice and require a prompt and cohesive response. Delays or perceived inconsistencies in the board’s response undermine the company’s position. The response to an unsolicited bid can put further stress on a board’s decision-making, as it can generate tremendous uncertainty and unease among the company’s various constituencies. The need for a quick response to an unsolicited M&A proposal underscores why companies must be prepared, both to avoid becoming the target of a hostile offer and to respond to an offer once made. Because the board is ultimately responsible for evaluating a proposed deal, directors must be aligned on key strategic issues. When a board is attuned to the arguments for, and likelihood of, alternative transactions, it can assess an unsolicited proposal’s merits with a higher degree of rigor. In building out its defensive toolkit, a company needs to develop a strong investor relations team with a strategy. A company must be able to show its shareholders that its board and management are focused on the company’s performance and stock price. Because goodwill with shareholders goes a long way in the face of an unsolicited bid, the company must also be proactive about investor outreach and engagement. A company’s strongest takeover defense is a tactical shareholder rights plan (commonly known as the “poison pill”). While their mechanics may vary, poison pills generally entail the issuance of rights to shareholders to purchase additional stock at a steep discount. When an unwelcome acquirer crosses a specified ownership threshold without board approval — often 15% — the poison pill activates, triggering the purchase rights for all holders except the party that exceeded the threshold. This results in significant dilution of the hostile acquirer. Because poison pills are such powerful deterrents to unsolicited bids, institutional shareholders and proxy voting advisers have long argued that directors only adopt poison pills to entrench themselves and engage in actions that destroy shareholder value. The efforts of institutional shareholders and proxy voting advisers have led to a prevailing belief that poison pills are contradictory to shareholders’ best interests and have driven them largely out of fashion. However, the poison pill has made a bit of a comeback in the U.S., and its recent use outside the country necessitate an awareness of its limitations. A hostile acquirer can also turn to a proxy contest to circumvent a poison pill. In a proxy contest, an acquiring party convinces other shareholders to vote with it to win control of the board or force desired changes in business strategy. Despite its potential limitations, however, the poison pill can effectively stall for time so that a board may more thoroughly assess an unsolicited offer and create more leverage in compelling negotiations between the acquirer and the board. The staggered board was once seen as one of the strongest shields against unsolicited M&A bids. A company with a staggered board divides its directors into three classes and puts only one class up for election at a given annual meeting. As a result, only one-third of the directors can be replaced in any year, dragging out the time required for a hostile acquirer to seize control of the board while simultaneously giving the board more time to respond to takeover bids. Although it was historically a primary line of defense against unsolicited bids, only 10% of S&P 500 companies today feature a staggered board, down from 60% in 2006. This precipitous decline is the result of pressure from activist investors who cite the staggered structure as an impediment to effective corporate governance. Such activists criticize the staggered board for encouraging board entrenchment, which they argue discourages responsiveness to shareholders. Nevertheless, it’s unlikely that the staggered board will disappear anytime soon. Because the staggered structure eliminates the pressure of annual reelections, a board that is staggered can more easily pursue a long-term business strategy, which is ideal for younger companies and those that prioritize innovation or invest heavily in research and development activities. While the poison pill and staggered board are widely recognized as the most effective takeover defenses, companies may consider implementing other safeguards. Directors should be creative in identifying new defenses that are better adapted to the current environment. Activists are increasingly coupling traditional media forms with social media — including platforms such as Instagram, Reddit, TikTok, and X — to find support for their messaging. Last October, Elliott Management added yet another digital weapon to activists’ arsenal by launching a podcast as part of its campaign against Southwest Airlines (LUV). Though activists have invested considerable resources into making their campaigns more media-savvy in recent years, “Stronger Southwest” marks the first time the podcast medium has been used to directly influence a company’s shareholder base. Moreover, it swiftly reached a critical mass of shareholders—within just a week of publication, its first episode amassed nearly 3,000 views on YouTube, with more listeners tuning in through Spotify and Apple. Directors should be aware of novel media forms, which may be particularly effective at influencing retail investors or other smaller, individual investors. Significant unsolicited M&A activity will likely continue in the coming years, given market and policy uncertainty. Consequently, once-popular takeover defenses may see renewed use, especially as boards step up their efforts to protect falling stock prices and deliver long-term value. Companies will also adjust their defense strategies to account for new trends in the activist space. The increasingly aggressive tactics that activists and other acquirers are adopting suggest unsolicited and hostile activity will remain an important component of the M&A landscape. A strong preparedness and response strategy will be crucial in such an environment.

Read the article